Major hospitals in India have oncology units comprising surgical oncology, medical and radiation therapy as well as the crucial Bone Marrow Transplantation (BMT). The BMT unit with high pressure hipa filters has helped achieve a very high success rate in the various types of transplantation.

Dr. Ajit Pai, M.Ch. DNB. MRCS, Consultant - Surgical Oncologist
Department of Surgical Oncology

The Department of Surgical Oncology is headed by Dr. Ajit Pai, who trained in surgical oncology at the Tata Memorial Hospital, Mumbai for 6 years. He obtained further specialized training in surgery for liver, biliary and pancreatic cancers at Tokyo, Nagoya and Kyoto Universities, and in keyhole surgery for esophageal cancer at Osaka university school of medicine, Japan. He also completed a fellowship in pancreatic cancer surgery at the University of Heidelberg, Germany. His special interests are in keyhole surgery for esophageal cancer and surgery for liver, pancreatic and gastrointestinal cancers.

The Department Surgical Oncology is aided by an American qualified pathologist and haematopathologist.

Dr. Bellarmine, M.D., A.B., F.A.C.P
Consultant in Medical Oncology & Haematology

The Department of Medical Oncology is headed by Dr. Bellarmine who is an Emeritus Member of American Society of Clinical Oncology. Dr. Bellarmine has 30 years of experience as Medical Oncologist and 9 yrs of professional experience as Professor in various prestigious centres in Tamil Nadu (India), including SRMC. He holds Medical Oncology Fellowship from Hershey Medical Centre, Pennsylvania State University, USA and Internal Medicine Residency from West Virginia University, USA.

Here treatment for cancer is provided using Medicine – a) Injection and b) Tablets. The treatment is given once in 3 weeks and approximately for 6 months, depending upon the nature of cancer and patients health condition. All chemotherapy drugs are administered here. Side effects: Nausea and Vomiting for 1 or 2 days. The pioneering Department of Interventional Radiology is practised in the technique of infusing chemotherapy drugs through the artery. Monoclonal Antibodies and Thyrosine Kinase Inhibitors are available for the target therapy of cancers.

Monoclonal antibody therapy: It is the use of monoclonal antibodies (or mAb) to specifically target cells. The main objective is stimulating the patient's immune system to attack the malignant tumour cells and the prevention of tumour growth by blocking specific cell receptors.
 

Case Study 2

- Cancer Type: Parotid Tumour
- Diagnosis and treatment:

Young lady from overseas, presented with a large tumour over the right side of the face and jaw, arising from the parotid gland. She underwent a very major surgery to remove the parotid gland, the skin of the cheek, part of the jaw bone, and then plastic surgery using tissues from her back to fill the defect so created.

Case Study 3

- Cancer Type: Thyroid cancer
- Diagnosis and treatment:

40 year old man, presented with a hard Thyroid swelling of 3 years duration
Needle biopsy confirmed it was a Thyroid cancer, and he underwent complete removal of the Thyroid gland, and post operative Radioiodine treatment, and is doing well.

Case Study 4

- Tumour Type: Esophageal cyst
- Diagnosis and treatment:

24 year old lady from Sudan, Dysphagia since 1 year

CT scan showed a posterior mediastinal mass

At surgery, a cyst was removed from the esophageal wall

For Detailed Dossier on Bone Marrow Transplant Consultants, please write to us at  mktg@mediescapes.com